Preface; Psychiatric disorders - an overview; Section 1: Schizophrenia: The pathophysiology of schizophrenia; Monoaminergic approaches for the treatment of schizophrenia; Glutamatergic approaches for the treatment of schizophrenia; Treating the cognitive deficits of schizophrenia; Section 2: Depression, Anxiety and Sleep: The neurobiology of Depression and Anxiety; Beyond SSRIs: second generation reuptake inhibitors for the treatment of depression; Panic and Anxiety Disorders; Glutamate approaches towards the treatment of mood disorders; Modulation of HPA axis function as a treatment for mood disorders; Neuropeptides receptors: novel therapeutic targets for depression and anxiety disorders; Sleep Disorders; Section 3: Other Psychiatric Disorders: Therapeutic approaches to bipolar disorder; Pharmacotherapies for drug addiction; Emerging research towards the understanding and treatment of Autism; Section 4: The Challenges of CNS Drug Discovery: Crossing the blood-brain-barrier - methods for evaluating CNS exposure; Medicinal Chemistry challenges in CNS drug discovery; Animal models of psychiatric disorders; Translational Imaging research in psychiatry; Section 5: Case Studies: Discovery of a Novel Clinical AMPA Receptor Positive Modulator; Orexin Antagonists for Insomnia - 14 years from genetics to patients; Index.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Psicofarmacología -- Libros electrónicos.
موضوع مستند نشده
Psicofármacos -- Libros electrónicos.
رده بندی کنگره
شماره رده
RM315
نشانه اثر
.
E358
2012
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )